全自动血凝仪市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

全自动血凝仪市场按产品类型(血凝仪仪器、耗材、附件)、最终用户和地理位置进行细分。

市场快照

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于血液相关疾病和开发产品的日益流行,全自动凝血仪预计将在预测期内实现快速增长。

  •  血友病是一种遗传性的血液疾病,它会阻止血液凝结。根据世界血友病联合会的数据,2018 年,全球约有 210,454 人被诊断出患有血友病。
  •  此外,冯维勒布兰德病流行病例约为 78,547 例,其他出血性疾病约为 48,640 例。预计这将推动对全自动血凝仪的需求。然而,仪器的高成本预计将阻碍市场增长。

报告范围

血凝仪是一种用于分析止血机制的设备。它检测血液和血管中的血栓,从而有助于识别与血液和心血管相关的疾病。市场按产品类型、最终用户和地理位置进行细分。

By Product Type
Coagulation System
Consumables
Accessories
By End User
Hospitals
Diagnostic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

医院板块有望在全自动市场占据主要市场份额

  • 越来越多的医院和不断发展的基础设施正在增加对全自动血凝仪设备的需求。根据美国医院协会的数据,美国大约有 5,198 家社区医院。此外,根据医疗保险和医疗补助服务中心的数据,美国政府在 2018 年用于改善医疗基础设施的支出比前一年增加了约 4.6%。
  • 此外,由于其快速诊断和结果,医院越来越多地采用即时检测,预计将推动对全自动血凝仪的需求。
Fully Automated Coagulometer Market Trend.png

北美预计将在市场上占有重要份额,预计在预测期内也将如此

由于与血液和心血管相关的疾病负担不断增加,预计北美将在市场上占据主要市场份额。根据世界血友病联合会 2018 年公布的数据,美国约有 36,262 人被发现患有其他一些血液疾病。此外,根据疾病控制和预防中心的数据,2017 年,约有 1820 万 20 岁及以上的人患有冠状动脉疾病。因此,预计这一因素将推动全自动血凝仪市场的增长。

Fully Automated Coagulometer Market - Growth Rate by Region

竞争格局

公司的产品发布和战略联盟预计将推动全自动分析仪市场的增长。2017年,Instrument Laboratory收购了Accriva Diagnostics,将其产品线扩展到凝血和抗血小板治疗的即时诊断。此外,在 2018 年,堀场推出了全自动血凝仪,用于实验室的 Yumizen G800 和用于高工作量临床实验室的 Yumizen G1550。就市场份额而言,目前很少有主要参与者占据市场主导地位。目前主导市场的一些公司包括 HemoSonics LLC、西门子医疗保健、雅培实验室、F. Hoffmann-La Roche Ltd、Erba Group、Sysmex、Instrumentation Laboratory、Horiba、Haemonetics Corporation 和 Grifols SA。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Blood Related Diseases

      2. 4.2.2 Emerging Trends in Product

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Test

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Coagulation System

      2. 5.1.2 Consumables

      3. 5.1.3 Accessories

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostic Laboratories

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Erba Group

      3. 6.1.3 F. Hoffmann-La Roche Ltd

      4. 6.1.4 Grifols SA

      5. 6.1.5 HemoSonics LLC

      6. 6.1.6 Haemonetics Corporation

      7. 6.1.7 Horiba

      8. 6.1.8 Instrumentation Laboratory

      9. 6.1.9 Siemens Healthcare

      10. 6.1.10 Sysmex

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Fully Automated Coagulometer Market market is studied from 2018 - 2026.

The Fully Automated Coagulometer Market is growing at a CAGR of 8.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

HemoSonics LLC , Siemens Healthcare , Instrumentation Laboratory, Abbott Laboratories, F. Hoffmann-La Roche Ltd. are the major companies operating in Fully Automated Coagulometer Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!